At ACC 2017 the RE-CIRCUIT study was presented in the Late-Breaking Clinical Trials session. Here we have a series of Q&A videos presented by Dr. Hugh Calkins Q&A 1: How do the absolute major bleeding event rates seen in RE-CIRCUIT for dabigatran etexilate and warfarin relate to those usually seen in clinical practice? Q&A 2: […]
Scott Hao Global Product Manager for Cardiovascular Ultrasound – highlighting Siemens Healthineers flagship ultrasound system For more information, please visit https://www.siemens-healthineers.com/en-uk/
In this video Dr. Gillard lectures on the basic anatomy and physiology of the heart’s conduction system. Students, please listen to this prior to the beginning of the electrophysiology/electrocardiogram section of the course.
In the video Dr. Gupta summarized the results of the RE-CIRCUIT study confirming the safety profile of dabigatran also in the setting of catheter ablation in AF patients. He explains that based on the RE-CIRCUIT results, interruption of dabigatran prior to ablation is no longer warranted, as reflected in current expert guidance for performing AF […]